Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LC-MS/MS Determination of Omarigliptin & Trelagliptin in Healthy Volunteers
NCT03362398Completed
- Sponsor
- The British University in Egypt
- Start
- Nov 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Omarigliptin Arm with Trelagliptin Arm (2 arms). Primary endpoint: Human plasma concentration of Omarigliptin or Trelagliptin at 1.5 hours. Started Nov 2017; status: completed.
02
Drugs
omarigliptintrelagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03362398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03362398.